Contact PR

To use this feature, join Babbler easily !

arrow_back

Babbler allows PR people and reporters to collaborate a better way.

By joining Babbler you will be able to access hundreds of newsrooms and PR contacts from your industrie(s) and also share with them your upcoming needs.

Their newsrooms are already on Babbler

You're 1 click away from signing up

Previous

Nice to see you again !

Press release

Sanofi at IDF 2019
timer minutes reading time minute reading time

Copy link
SANOFI'S STRONG SCIENTIFIC CONTRIBUTION TO IDF 2019

Click to get original image size

We are proud to demonstrate our long-standing commitment to people living with diabetes, and our comprehensive approach to addressing their individual needs at this year’s International Diabetes Federation congress, with more than 13 scientific contributions to the congress program. Sanofi’s engagement at IDF 2019 showcases continuing advances in individualized care, to help improve health and quality of life for people with diabetes worldwide.

We are presenting new evidence from across our diabetes portfolio, including head to head clinical data, a network meta-analysis, and new data from the International Diabetes Management Practices Study (IDMPS). Highlights include:

The iGlarLaxi meta-analysis: Findings from a network meta-analysis on gastrointestinal adverse events

The new Bayesian network meta-analysis of 17 clinical trials evaluates rates of gastrointestinal adverse events in adults with type 2 diabetes, comparing Soliqua* (insulin glargine 100 Units/mL and lixisenatide, iGlarLixi) vs glucagon-like peptide-1 receptor agonists (GLP-1RAs) Rayner C.K, et al. Oral poster presentation 

The BRIGHT trial: Post-hoc sub-analysis builds on results from BRIGHT head to head clinical trial

The new post-hoc sub-analysis evaluates blood sugar control in adults with type 2 diabetes and impaired renal function at high risk of hypoglycemia, comparing Toujeo (insulin glargine 300 Units/mL) vs insulin degludec 100 Units/mL Cheng A., et al. Oral poster presentation

The International Diabetes Management Practices Study (IDMPS): A worldwide observational study of adult diabetes in developing countries IDMPS Chronic Kidney Disease Study: Demonstrates frequency of screening and chronic kidney disease in adults with type 1 and type 2 diabetes Mbyana J.C., et al. Oral poster presentation

IDMPS Type 1 Diabetes Education Study: Evaluates impact of diabetes education and self-management on achieving blood sugar targets in adults with type 1 diabetes Chan J., et al. Oral poster presentation

IDMPS Type 2 Diabetes Unmet Needs Study: Evaluation of unmet medical needs in adults with type 2 diabetes treated with insulin Ramachandran A., et al. Poster presentation

IDMPS Wave 8 Study Design: A novel real-world crosssectional and longitudinal design to evaluate management of insulin in adults with type 2 diabetes Ilkova H., et al. Oral poster presentation

SANOFI SYMPOSIA Diabetes journey: Innovative solutions for individual needs Tuesday, December 3. 17:30–19:30 Summit Hall – Room 205, Busan Exhibition and Convention Centre

inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here